Focus-X Therapeutics
ExitedPreclinical stage biotechnology company committed to the discovery and development of cutting-edge radiopharmaceuticals.
Focus-X Therapeutics is tracked in the Tech.eu funding database. Based in New Jersey, United States; active in Healthtech. Acquired by Full-Life Technologies in 2022. Data as of Nov 2026.
New Jersey, United StatesFocus-X Therapeutics ↗
Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—
Funding rounds
0 roundsNo funding rounds recorded.
Exit
Type
acquisition
Date
Nov 2022
Value
€237M
Acquiror
Full-Life Technologies (Belgium)
Related news
- Full-Life Technologies to Acquire Focus-X Therapeutics, for Up To $245Mfinsmes.com · 2022-11
Similar companies
same sector, similar size- Sencilia—Netherlands · Healthtech
- Clinithink—UK · Healthtech
- Care—Switzerland · Healthtech
- TimeTeller—Germany · Healthtech
- NeoPrediX—Germany · Healthtech
- Chiron Health AI—UK · Healthtech
Global coverage: FundingData